ConductScience.org, home

Paper28972796

PET imaging in anal canal cancer: a systematic review and meta-analysis.

Mahmud A and 2 others. Br J Radiol, 2017. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. PET imaging in anal canal cancer: a systematic review and meta-analysis. Papers, record 28972796. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28972796

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PET imaging in anal canal cancer: a systematic review and meta-analysis.
PubMed
Journal
Br J Radiol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2025-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahmud AAamer
2Poon RRaymond
3Jonker DDerek

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
Positron-Emission TomographyMajor topic
Anal Canal
Humans

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123208584MRI and CT of anal carcinoma: a pictorial review.Insights Imaging2013https://conductscience.org/library/papers/23208584PubMed
28823332
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
J Clin Oncol1996https://conductscience.org/library/papers/8823332PubMed
322294527To PET or not to PET? That is the question. Staging in anal cancer.Ann Oncol2012https://conductscience.org/library/papers/22294527PubMed
419259091The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.Br J Cancer2009https://conductscience.org/library/papers/19259091PubMed
519370429Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?Strahlenther Onkol2009https://conductscience.org/library/papers/19370429PubMed
626126968Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.Radiol Med2016https://conductscience.org/library/papers/26126968PubMed
718614927Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.J Acquir Immune Defic Syndr2008https://conductscience.org/library/papers/18614927PubMed
819404066Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.Dis Colon Rectum2009https://conductscience.org/library/papers/19404066PubMed
916028002Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.Mol Imaging Biol2005https://conductscience.org/library/papers/16028002PubMed
1022915424Imaging of anal carcinoma.AJR Am J Roentgenol2012https://conductscience.org/library/papers/22915424PubMed
119164216
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
J Clin Oncol1997https://conductscience.org/library/papers/9164216PubMed
1221061012Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma.Int J Colorectal Dis2011https://conductscience.org/library/papers/21061012PubMed
1319736891Squamous cell carcinoma of the anal canal.Surgeon2009https://conductscience.org/library/papers/19736891PubMed
1425239441Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.Eur J Surg Oncol2014https://conductscience.org/library/papers/25239441PubMed
1519926961Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.AIDS2010https://conductscience.org/library/papers/19926961PubMed
1619394179FDG-PET/CT: new horizons in anal cancer.Gastroenterol Clin Biol2009https://conductscience.org/library/papers/19394179PubMed
1715494916Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.Clin Infect Dis2004https://conductscience.org/library/papers/15494916PubMed
1816626889FDG-PET/CT in the evaluation of anal carcinoma.Int J Radiat Oncol Biol Phys2006https://conductscience.org/library/papers/16626889PubMed
1920231040Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.Radiother Oncol2010https://conductscience.org/library/papers/20231040PubMed
2021685461Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin2011https://conductscience.org/library/papers/21685461PubMed

See all 40 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
42582979Optimising chemoradiotherapy in anal cancer.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42582979PubMed
42255977Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.Clin Transl Radiat Oncol2026https://conductscience.org/library/papers/42255977PubMed
42073557Imaging Biomarkers in Radiotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42073557PubMed
41555561Diagnostic and Therapeutic Impact of FDG-PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta-Analysis.J Med Imaging Radiat Oncol2026https://conductscience.org/library/papers/41555561PubMed
40963852Clinical evaluation of atlas-based auto-segmentation for contouring pelvic CTVs in the treatment of anal cancer with FDG-PET-positive lymph node involvement.Front Oncol2025https://conductscience.org/library/papers/40963852PubMed
39542884Interstitial HDR brachytherapy for anal cancer-results and quality of life.Strahlenther Onkol2025https://conductscience.org/library/papers/39542884PubMed
39390445Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using 18F-FDG PET/CT.BMC Cancer2024https://conductscience.org/library/papers/39390445PubMed
39312693Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment.World J Exp Med2024https://conductscience.org/library/papers/39312693PubMed
37736988An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer.Tomography2023https://conductscience.org/library/papers/37736988PubMed
37592085[18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/37592085PubMed
37296929The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature.Cancers (Basel)2023https://conductscience.org/library/papers/37296929PubMed
37042989[Diagnostics, treatment and aftercare of anal cancer].Chirurgie (Heidelb)2023https://conductscience.org/library/papers/37042989PubMed
37024606Follow-up imaging of anal cancer after treatment.Abdom Radiol (NY)2023https://conductscience.org/library/papers/37024606PubMed
36975459Anal Cancer: The Past, Present and Future.Curr Oncol2023https://conductscience.org/library/papers/36975459PubMed
36932225Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.Abdom Radiol (NY)2023https://conductscience.org/library/papers/36932225PubMed
36862155Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.Strahlenther Onkol2023https://conductscience.org/library/papers/36862155PubMed
36611345The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review.Diagnostics (Basel)2022https://conductscience.org/library/papers/36611345PubMed
35908126Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.Dig Dis Sci2022https://conductscience.org/library/papers/35908126PubMed
35719920Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer.Front Oncol2022https://conductscience.org/library/papers/35719920PubMed
35406469A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35406469PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28972796

GET https://conductscience.org/api/papers/v1/28972796/references?page=2